Pfizer reported that its ultra-long-acting, once-monthly GLP-1 injectable achieved up to 12.3% placebo-adjusted weight loss by week 28, with no weight-loss plateau, in adults with obesity or overweight without type…
Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.
New Delhi: The Indian Pharmaceutical Market (IPM) started calendar year 2026 with a robust uptick, delivering 10.21% month-on-month value growth and 1.82% unit growth in January, data from PharmaTrac MAT…
New Delhi: Aurobindo Pharma Limited recently informed that the United States Food and Drug Administration (USFDA) has completed an inspection at its Unit-VII manufacturing facility located at Jedcherla in Telangana.…
New Delhi: Mankind Pharma Limited has informed the stock exchanges that the Goods and Services Tax (GST) Department, Mumbai, carried out a search and inspection operation at Bharat Serums and…
New Delhi: OneSource Specialty Pharma Limited has received regulatory approval in Saudi Arabia to commercialise a generic version of Ozempic (semaglutide), marking a significant milestone for the company's expansion in…
Experts say the FDA "moved the goalposts" on Moderna, creating "a destructive precedent that will undermine the future of vaccine development" in the U.S.
Mumbai: Pharma major Lupin has announced the completion of a cGMP inspection carried out by the United States Food and Drug Administration (USFDA) at its Tarapur facility. The inspection closed…
Findings from the APPEAL study, published in ACR Open Rheumatology, reveal that falls are a frequent but underrecognized complication among individuals with systemic lupus erythematosus (SLE). Researchers analyzed data from…
This is the web edition of STAT's D.C. Diagnosis newsletter.